Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal vs IV Dexmedetomidine in Nasal Endoscopic Surgeries
NCT07012213Phase 1Not yet recruiting
- Sponsor
- Cairo University
- Start
- Oct 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in paranasal sinus disease (2 arms), sponsored by Cairo University. Primary endpoint: Intraoperative fentanyl consumption at 40 minutes. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on NCT07012213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012213.